Lori Anne Kunkel

Insider Reports History

Entity
Individual
Location
C/O Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA
Signature
/s/ Christian Kuhlen, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lori Anne Kunkel:

Insider Reports Filed by Lori Anne Kunkel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ORIC Oric Pharmaceuticals, Inc. Mar 3, 2025 4 $234K 4 Mar 4, 2025 Director
ELVN Enliven Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 Director
ORIC Oric Pharmaceuticals, Inc. Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
NRIX Nurix Therapeutics, Inc. Jul 17, 2024 1 $0 4 Jul 18, 2024 Director
ORIC Oric Pharmaceuticals, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
ORIC Oric Pharmaceuticals, Inc. Jun 3, 2024 2 $76.9K 4 Jun 4, 2024 Director
NRIX Nurix Therapeutics, Inc. May 20, 2024 1 $0 4 May 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Apr 8, 2024 1 $0 4 Apr 10, 2024 Director
ELVN Enliven Therapeutics, Inc. Apr 8, 2024 0 $0 3 Apr 10, 2024 Director
ORIC Oric Pharmaceuticals, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
NRIX Nurix Therapeutics, Inc. May 4, 2023 1 $0 4 May 4, 2023 Director
ORIC Oric Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 17, 2022 Director
NRIX Nurix Therapeutics, Inc. May 5, 2022 1 $0 4 May 6, 2022 Director
CRIS CURIS INC Jan 31, 2022 1 $0 4 Jan 31, 2022 Director
ORIC Oric Pharmaceuticals, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
NRIX Nurix Therapeutics, Inc. May 6, 2021 1 $0 4 May 24, 2021 Director